Priyanka Roy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Priyanka Roy has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- John G. Doench
Genetic Perturbation Platform, Broad Institute, Cambridge, USA
3 shared publications - Annabel K. Sangree
Division of Human Genetics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
2 shared publications - Audrey L. Griffith
Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, USA
2 shared publications - Mudra Hegde
Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, USA
2 shared publications - Abby V. McGee
University of Washington
1 shared publication Ahsan Kabir Nuhel
American International University-Bangladesh (AIUB),Electrical and Electronics Engineering
1 shared publication
Latest Publications
- 2 March 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 7-12
Development of an Agro-Photovoltaic Transparent Solar Panel and DOCR for Agriculture and Grid System Usage
Providing space for both power plants and agriculture can be a significant difficulty for densely populated nations with limited land. In this paper, transparent photovoltaic (PV) panels are utilized to construct a solar power plant that can simultaneously produce electricity to the national grid and serve as land for agriculture, as sunlight can penetrate through transparent PV panels. This will allow the system to generate electricity in frames land without harming the agriculture. In addition to enhancing agricultural output, agro-photovoltaic adds to the provision of off-grid power in developing and rural regions. For enhancing the protection of the system Directional Over current relay (DOCR) is used for analyzing the faults. To connect the power plant in the load, the hardware specifications of transparent PV panels, boost converters, inverters, and transformers is reviewed in depth.
- 2 March 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 7-12
Development of an Agro-Photovoltaic Transparent Solar Panel and DOCR for Agriculture and Grid System Usage
Providing space for both power plants and agriculture can be a significant difficulty for densely populated nations with limited land. In this paper, transparent photovoltaic (PV) panels are utilized to construct a solar power plant that can simultaneously produce electricity to the national grid and serve as land for agriculture, as sunlight can penetrate through transparent PV panels. This will allow the system to generate electricity in frames land without harming the agriculture. In addition to enhancing agricultural output, agro-photovoltaic adds to the provision of off-grid power in developing and rural regions. For enhancing the protection of the system Directional Over current relay (DOCR) is used for analyzing the faults. To connect the power plant in the load, the hardware specifications of transparent PV panels, boost converters, inverters, and transformers is reviewed in depth.
- 25 July 2022
- Published by Springer Nature in Nature Genetics
- Vol. 54 (8) , 1090-1102
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
CRISPR knockout (KO) screens have identified host factors regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. Here, we conducted a meta-analysis of these screens, which showed a high level of cell-type specificity of the identified hits, highlighting the necessity of additional models to uncover the full landscape of host factors. Thus, we performed genome-wide KO and activation screens in Calu-3 lung cells and KO screens in Caco-2 colorectal cells, followed by secondary screens in four human cell lines. This revealed host-dependency factors, including AP1G1 adaptin and ATP8B1 flippase, as well as inhibitors, including mucins. Interestingly, some of the identified genes also modulate Middle East respiratory syndrome coronavirus (MERS-CoV) and seasonal human coronavirus (HCoV) (HCoV-NL63 and HCoV-229E) replication. Moreover, most genes had an impact on viral entry, with AP1G1 likely regulating TMPRSS2 activity at the plasma membrane. These results demonstrate the value of multiple cell models and perturbational modalities for understanding SARS-CoV-2 replication and provide a list of potential targets for therapeutic interventions.
- 25 July 2022
- Published by Springer Nature in Nature Genetics
- Vol. 54 (8) , 1090-1102
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
CRISPR knockout (KO) screens have identified host factors regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. Here, we conducted a meta-analysis of these screens, which showed a high level of cell-type specificity of the identified hits, highlighting the necessity of additional models to uncover the full landscape of host factors. Thus, we performed genome-wide KO and activation screens in Calu-3 lung cells and KO screens in Caco-2 colorectal cells, followed by secondary screens in four human cell lines. This revealed host-dependency factors, including AP1G1 adaptin and ATP8B1 flippase, as well as inhibitors, including mucins. Interestingly, some of the identified genes also modulate Middle East respiratory syndrome coronavirus (MERS-CoV) and seasonal human coronavirus (HCoV) (HCoV-NL63 and HCoV-229E) replication. Moreover, most genes had an impact on viral entry, with AP1G1 likely regulating TMPRSS2 activity at the plasma membrane. These results demonstrate the value of multiple cell models and perturbational modalities for understanding SARS-CoV-2 replication and provide a list of potential targets for therapeutic interventions.
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , SY05-02
Abstract SY05-02: Applications of base editor technology in small molecule: Target validation
CRISPR screens that focus on the gene as the unit of information - whether using knockout, interference, or activation - have reinvigorated the field of functional genomics. The recent development of Base Editor technology allows nucleotide-level manipulation, enabling fine-scale investigation of endogenous loci. The low upfront costs of generating a pooled base editing library, coupled with the small scale and relative ease of executing such screens, makes the financial barrier to entry for such experiments low while also not requiring deep experience with screening. One application of this technology is screens that aim to identify resistance mutations in putative targets of small molecules, which provides excellent evidence that the phenotype is caused by on-target activity of the small molecule. This has heretofore typically been an extraordinarily laborious and time-consuming experimental path, by either slowly cultivating spontaneous drug resistant mutants or by generating and screening large scale ORF-variant pools. Base editor screens are well-suited to vastly accelerate this process. Using both A>G and C>T base editors, coupled with variants of the SpCas9 enzyme, we have conducted drug resistance screens with small molecules that target the anti-apoptotic proteins MCL1, BCL2L1, and BCL2, as well as the DNA repair regulator PARP1. These screens identified resistance residues that were also observed in clinical samples, illustrating the utility of this approach. Additionally, base editor screens are excellent tools for studying genetic variants, as we will demonstrate with screens identifying loss-of-function mutations in BRCA1, BRCA2, and TP53. We anticipate that the tools and methodologies described here will facilitate the investigation of impactful variants at a finer and deeper resolution for any locus of interest. Citation Format: Audrey Griffith, Annabel Sangree, Priyanka Roy, Ruth Hanna, John Doench. Applications of base editor technology in small molecule: Target validation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr SY05-02.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , SY05-02
Open AccessAbstract SY05-02: Applications of base editor technology in small molecule: Target validation
CRISPR screens that focus on the gene as the unit of information - whether using knockout, interference, or activation - have reinvigorated the field of functional genomics. The recent development of Base Editor technology allows nucleotide-level manipulation, enabling fine-scale investigation of endogenous loci. The low upfront costs of generating a pooled base editing library, coupled with the small scale and relative ease of executing such screens, makes the financial barrier to entry for such experiments low while also not requiring deep experience with screening. One application of this technology is screens that aim to identify resistance mutations in putative targets of small molecules, which provides excellent evidence that the phenotype is caused by on-target activity of the small molecule. This has heretofore typically been an extraordinarily laborious and time-consuming experimental path, by either slowly cultivating spontaneous drug resistant mutants or by generating and screening large scale ORF-variant pools. Base editor screens are well-suited to vastly accelerate this process. Using both A>G and C>T base editors, coupled with variants of the SpCas9 enzyme, we have conducted drug resistance screens with small molecules that target the anti-apoptotic proteins MCL1, BCL2L1, and BCL2, as well as the DNA repair regulator PARP1. These screens identified resistance residues that were also observed in clinical samples, illustrating the utility of this approach. Additionally, base editor screens are excellent tools for studying genetic variants, as we will demonstrate with screens identifying loss-of-function mutations in BRCA1, BRCA2, and TP53. We anticipate that the tools and methodologies described here will facilitate the investigation of impactful variants at a finer and deeper resolution for any locus of interest. Citation Format: Audrey Griffith, Annabel Sangree, Priyanka Roy, Ruth Hanna, John Doench. Applications of base editor technology in small molecule: Target validation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr SY05-02.
- Open Access
- 14 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
Numerous rationally-designed and directed-evolution variants of SpCas9 have been reported to expand the utility of CRISPR technology. Here, we assess the activity and specificity of WT-Cas9 and 10 SpCas9 variants by benchmarking their PAM preferences, on-target activity, and off-target susceptibility in cell culture assays with thousands of guides targeting endogenous genes. To enhance the coverage and thus utility of base editing screens, we demonstrate that the SpCas9-NG and SpG variants are compatible with both A > G and C > T base editors, more than tripling the number of guides and assayable residues. We demonstrate the performance of these technologies by screening for loss-of-function mutations in BRCA1 and Venetoclax-resistant mutations in BCL2, identifying both known and new mutations that alter function. We anticipate that the tools and methodologies described here will facilitate the investigation of genetic variants at a finer and deeper resolution for any locus of interest.
- 14 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessBenchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
Numerous rationally-designed and directed-evolution variants of SpCas9 have been reported to expand the utility of CRISPR technology. Here, we assess the activity and specificity of WT-Cas9 and 10 SpCas9 variants by benchmarking their PAM preferences, on-target activity, and off-target susceptibility in cell culture assays with thousands of guides targeting endogenous genes. To enhance the coverage and thus utility of base editing screens, we demonstrate that the SpCas9-NG and SpG variants are compatible with both A > G and C > T base editors, more than tripling the number of guides and assayable residues. We demonstrate the performance of these technologies by screening for loss-of-function mutations in BRCA1 and Venetoclax-resistant mutations in BCL2, identifying both known and new mutations that alter function. We anticipate that the tools and methodologies described here will facilitate the investigation of genetic variants at a finer and deeper resolution for any locus of interest.